IPaT Executive Director Beth Mynatt will represent Georgia Tech today at the launch of President Barack Obama's Precision Medicine initiative.
The goal of precision medicine —also known as personalized medicine —is to identify and treat the exact form of disease in patients based on their genome. It also looks at other factors like the interaction of genes and environment, and the body's microbes. This approach also allows doctors to tailor drugs to each individual and avoid ineffective or harmful drugs. At the event launch, the President will host academics, scientists and government officials to announce details of the new initiative.
“We're excited about the Precision Medicine initiative,” said Mynatt. “At Georgia Tech, we have an aggressive research program that integrates genetic, behavioral, and environmental information to create personalized heath and wellness interventions. These interventions are clearly showing the potential to improve health across the country through precision medicine approaches."
Mynatt leads an NIH project to create personalized support for breast cancer patients. Last month, she discussed her research at President’s Cancer Panel.
